Brief: United Therapeutics Unveils $2 Bln Buyback Plan, Launches $1.5 Bln Accelerated Repurchase
09/03/2026 11:16
March 9 (Reuters) - United Therapeutics Corp UTHR.O: UNITED THERAPEUTICS CORPORATION ANNOUNCES $2 BILLION STOCK REPURCHASE AUTHORIZATION AND ENTERS INTO $1.5 BILLION ACCELERATED SHARE REPURCHASE PROGRAM UNITED THERAPEUTICS CORP - $500 MILLION REMAINS AVAILABLE FOR ADDITIONAL REPURCHASES OVER ONE-YEAR PERIOD Source text: ID:nBwyzkgxa Further company coverage: UTHR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on United Therapeutics
See all newsBrief: United Therapeutics Corporation Announces Additional $2 Billion Share Repurchase Authorization
Brief: United Therapeutics Announces FDA Clearance To Proceed With Summit Clinical Trial For Treprostinil Smi In Ph-Copd
Liquidia surges as United Therapeutics settlement removes key litigation risk (updated)
Brief: United Therapeutics Enters Settlement Agreement With Liquidia To Resolve Litigation - SEC Filing
Liquidia surges after $381 million settlement with United Therapeutics for lung disease drug